Skip to main content

Advertisement

Table 7 Comparison of adverse perinatal outcomes in pregnant women with and without metabolic syndrome according to four definitions

From: Prevalence of metabolic syndrome in non-diabetic, pregnant Angolan women according to four diagnostic criteria and its effects on adverse perinatal outcomes

Adverse perinatal outcome Entire study group (N = 675) NCEP ATP III [5] p value JIS MetS Criteria [6] p value NCEP ATP III (Bartha [10]) p value NHLBI/AHA (Chatzi [8, 9] p value
With MetS N = 197 Without MetS N = 478 With MetS N = 247 Without MetS N = 428 With MetS N = 12 Without MetS N = 663 With MetS N = 85 Without MetS N = 590
Visible malformation (%) 1 1 (0.5) 0 (0.0) 0.6468 0 (0) 1 (0.2) 1.0 0 (0.0) 1 (0.2) 1.0 0 (0.0) 1 (0.01) 1.0
Icterus (%) 4 2 (0.1) 2 (0.4) 0.7137 2 (0.8) 2 (0.5) 0.9699 0 (0.0) 4 (0.6) 1.0 1 (1.2) 3 (0.05) 1.0
Macrossomia 28 14 (7.1) 14 (2.9) 0.236 15 (6.0) 13 (3.0) 0.0882 2 (16.7) 26 (3.9) 0.1432 6 (7.0) 22 (3.7) 0.2507
Prematurity (%) 26 7 (3.5) 19 (3.9) 0.9691 9 (3.6) 17 (4.0) 0.9953 1 25 (3.7) 0.9544 5 (5.9) 21 (3.5) 0.4599
Respiratory Distress Syndrome (%) 14 3 (1.5) 11 (2.3) 0.7278 3 (1.2) 11 (2.6) 0.3628 0 (0.0) 14 (2.1) 1.0 2 (2.3) 12 (2.0) 1.0
Stillbirth (%) 15 6 (3.0) 9 (1.9) 0.5192 6 (2.4) 9 (2.1) 0.9952 2 (16.7) 13 (2.0) 0.0148 3 (3.5) 12 (2.0) 0.6305
Apgar score <7
 1 min (%) 31 6 (3.0) 25 (5.2) 0.3028 9 (3.6) 22 (5.1) 0.4816 0 (0.0) 31 (4.8) 0.9433 4 (4.7) 27 (4.6) 1.0
 5 min (%) 10 3 (1.5) 7 (1.5) 1.0 3 (1.2) 7 (1.6) 0.9161   10 (1.5) 1.0 1 (1.2) 9 (1.5) 1.0
Number of newborns with APO 95 30 (15.2) (a) 65 (13.6) 0.6658 36 (14.6) (a) 59 (13.8) 0.8655 4 (33.3) (a) 91 (13.7) 0.1293 15 (17.6) (a) 80 (13.5) 0.3973
Any adverse perinatal outcome APO N (%) 129 42 (21.3) (a) 87 (12.2) 0.4069 47 (19.0) (a) 82 (19.2) 1.000 5 (41.7) (a) 124 (18.7) 0.1021 22 (25.9) (a) 106 (18.0) 0.1112
  1. * Difference test of proportions of number of newborns with APO p = 0.3435 (aaa and a). * Difference test of proportions of any adverse perinatal outcomes is p = 0.1898